Al-Harmain Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 1.62 Cr
as on 19-12-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.02 M
as on 19-12-2024
- Satisfied Charges ₹ 2.00 Cr
as on 19-12-2024
- Revenue -31.55%
(FY 2020)
- Profit -0.24%
(FY 2020)
- Ebitda 407.86%
(FY 2020)
- Net Worth 5.32%
(FY 2020)
- Total Assets -25.80%
(FY 2020)
About Al-Harmain Pharma (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.62 Cr.
The company currently has active open charges totaling ₹1.02 M. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mohd Tariq, Saboor Siddiqui, and Mohammed Siddiqui serve as directors at the Company.
- CIN/LLPIN
U24232DL2004PTC128769
- Company No.
128769
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Al-Harmain Pharma (India) Private Limited offer?
Al-Harmain Pharma (India) Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Instant Drink Mix, Rose Sharbat, Herbs,Sticks and Roots, Ayurvedic Indian Herbs, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic, Unani Health Tonic, Ayurvedic & Herbal Products.
Who are the key members and board of directors at Al-Harmain Pharma (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohd Tariq  | Director | 02-Sep-2004 | Current |
| Saboor Siddiqui | Director | 02-Sep-2004 | Current |
| Mohammed Siddiqui | Director | 10-Jun-2021 | Current |
Financial Performance of Al-Harmain Pharma (India).
Al-Harmain Pharma (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 31.55% decrease. The company also saw a slight decrease in profitability, with a 0.24% decrease in profit. The company's net worth moved up by a moderate rise of 5.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Al-Harmain Pharma (India)?
In 2020, Al-Harmain Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 04 Aug 2022 | ₹0.41 M | Open |
Hdfc Bank Limited Creation Date: 01 Jul 2022 | ₹0.61 M | Open |
Others Creation Date: 27 Nov 2019 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Al-Harmain Pharma (India)?
Unlock and access historical data on people associated with Al-Harmain Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Al-Harmain Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Al-Harmain Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
